5th Gene Therapy Immunogenicity Summit 2024
Hanson Wade
20.08.2024 - 22.08.2024 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:30 AM - 4:00 PM
Temi della conferenza
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
Scientific organizer
Evvnt Promotion / evvnt
Evvnt Promotion / evvnt
Annotazioni
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832
Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832
Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2453359-2?pid=4832
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
